September 15, 2026
As initially announced in June this year, Proteome Sciences plc (AIM:PRM) is pleased to now confirm that the Company has secured the expected significant clinical contract for its chemoproteomics platform. This project has been developed to comply with Good Clinical Laboratory Practice (“GCLP”) accreditation and will be undertaken at our laboratories in Frankfurt, Germany.